T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
19 hedge funds and large institutions have $520K invested in T2 Biosystems, Inc in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
10% less funds holding
Funds holding: 21 → 19 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
62% less capital invested
Capital invested by funds: $1.37M → $520K (-$849K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.7K |
| 2 |
VF
Virtu Financial
New York
|
+$14.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.18K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.83K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$383 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$129K |
| 2 |
Jane Street
New York
|
-$96.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$64.7K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$14K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$5.78K |
TTOO Hedge Fund Activity: Q1 2024 in Review
19 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2024, worth a combined $520K — down 62% from $1.37M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TTOO and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $17.7K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $129K sold.
- 19 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2024, down from 21 in Q4 2023.
- Funds reported $520K of T2 Biosystems, Inc stock for Q1 2024, down 62% quarter-over-quarter.
- 2 funds opened new T2 Biosystems, Inc positions in Q1 2024 and 4 closed out, a net change of -2 holders.
- The largest T2 Biosystems, Inc buyer in Q1 2024 was Geode Capital Management, an estimated $17.7K added.
- The largest T2 Biosystems, Inc seller in Q1 2024 was GSA Capital Partners, an estimated $129K sold.
Based on aggregated 13F filings for Q1 2024.